Rodman & Renshaw Capital Group, Inc. Hires Gordon K. “Rusty” Johnson as Managing Director, Healthcare Investment Banking

NEW YORK--()--Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), today announced that Gordon K. “Rusty” Johnson, has joined the firm in the position of Managing Director, Healthcare Investment Banking, bringing his diverse healthcare investment banking experience and expertise to Rodman.

Edward Rubin, Rodman & Renshaw's Chief Executive Officer commented, “The addition of Rusty to our team demonstrates our deep commitment to the healthcare sector and continues to expand our service capabilities. As we focus on increasing our market share in serving the financing and strategic needs of life sciences companies, Rusty's proven track record, and his deep knowledge of the healthcare industry will continue to expand our capital markets and advisory presence in this sector.”

“I am very impressed by the entire Rodman team and the significant track record they have established in helping finance the life sciences industry, one of our country’s most dynamic and creative industries,” said Mr. Johnson. “I am looking forward to working as part of the Rodman team to continue and to help expand their successful efforts at financing and advising important life sciences companies in all phases of their growth.”

Mr. Johnson has over 30 years of investment banking experience and has completed numerous financings and advisory assignments for a wide variety of life sciences companies. Most recently, Mr. Johnson served as Managing Director, Healthcare Investment Banking at Piper Jaffray & Co. Prior to joining Piper Jaffray, Mr. Johnson was Managing Director and Head of Investment Banking and Healthcare Banking at WR Hambrecht + Co. In addition, Mr. Johnson has held investment banking positions at firms which include Deutsche Bank, Kidder, Peabody & Co. and Credit Suisse First Boston. Mr. Johnson began his career as a pharmaceutical marketing representative for The Upjohn Company.

Mr. Johnson holds a B.A. in Biology from the University of Missouri and an M.B.A. from Harvard Business School.

About Rodman & Renshaw, LLC

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of deal volume of PIPE and RD financing transactions completed every year since 2005.

For more information visit Rodman & Renshaw on the Internet at www.rodm.com.

MEMBER FINRA, SIPC

Contacts

Rodman & Renshaw Investor Relations
Grayling
Mr. Christopher Chu, 1-646-284-9400 (ext. 426)
Rodman@grayling.com

Contacts

Rodman & Renshaw Investor Relations
Grayling
Mr. Christopher Chu, 1-646-284-9400 (ext. 426)
Rodman@grayling.com